HKBU develops Chinese medicine for ulcerative colitis approved by National Medical Products Administration for clinical trial

HONG KONG, Sept. 4, 2024 /PRNewswire/ — The Centre for Chinese Herbal Medicine Drug Development (CDD) at Hong Kong Baptist University (HKBU) has achieved a significant milestone in developing a novel Chinese herbal formulation for ulcerative colitis remission maintenance. Following a…